Yes its been used as the brand name "Elmiron" in a pill format. Bio-Availability for such conditions as OA is low in Pill format.
Thus needs injections. But for new applications (such as OA, MPS, RRV etc) they need clinical trials to prove they are safe, effective etc.
PAR -v- CUV, page-12
-
- There are more pages in this discussion • 117 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.73M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 23.0¢ | 22.0¢ | $48.08K | 214.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 187472 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 27955 | 8 |
View Market Depth
| Last trade - 11.08am 05/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |